Verge Genomics

Verge Genomics is a technology-driven drug discovery company that is pioneering the use of artificial intelligence (AI) and human data to develop new drugs. Verge Genomics is a next-generation biopharmaceutical startup utilizing systems biology to accelerate the development of therapies for neurodegenerative diseases. Our platform leverages patient genomics, gene expression, and epigenomics to identify novel therapeutic gene targets, predict effective drugs, and stratify patient subgroups to enhance clinical success rates. This presents a groundbreaking opportunity to discover drugs that can significantly improve patient outcomes while fundamentally reducing the cost curve of drug development.